Skip to main content
. 2006 Sep 20;91(2):204–209. doi: 10.1136/bjo.2006.101725

Table 2 Clinical summary of 35 cases of steroid‐treated temporal arteritis.

Case Length of artery (mm) Eye involved Age (years) Sex Race ESR (mm/h) Corticosteroid dosage (mg) Duration of treatment (days) Cumulative dose (mg)
1 16 OD 75 F C 96 60 7 420
2 10 OS 76 F C 100 30 3 90
3 15 OD 77 F C 58 60 60 3600
4 9 OS 64 M C NK 60 45 2700
5 16 OD 60 F C 134 60 5 300
6 21 OS 75 M C 76 60 5 300
7 15 OD 82 F C 100 40 42 1680
8 8 OD 86 F C 110 60 16 220
9 20 OD 62 M C NK 100 3 300
10 23 OD 76 F C 112 IVMP 1000 3 3000
11 31 OD 71 F C NK 60 90 5400
12 12 OS 63 F C 115 100 4 400
13 15 OS 70 F C 22 80 7 560
14 7 OD 75 M C 99 IVMP 1000 3 3000
15 NK OS 74 F C 58 IVMP 1000 3 3000
16 10 OD 71 F C 53 60 21 1260
17 12 OD 79 F C 75 60 4 240
18 20 OD 68 F NK NK IVMP 1000×3 days, 100 6 weeks, 80 2 weeks 60 8320
19 NK OD 69 F C 45 40×3 days, 80×3 days 6 360
20 35 OS 67 M AA NK 60 10 600
21 25 OD 76 M C 115 80 5 400
22 NK OS 66 F NK 81 60 3 180
23 19 OD 74 F C 6 60 7 420
24 14 OS 78 M C 60 60 7 420
25 14 OD 80 M C 49 Medrol dose 10 g pack 3 months before Bx 3 300
26 16 OS 87 M C 10 200 IV×2 days 80×5 days
7 800
27 16 OS 87 M C 40 40×3 days 60×2 days
5 240
28 18 OS 67 F C 6 80 10 800
29 15 OD 74 M C 38 100×6 days Medrol dose pack (150 mg total)
7 750
30 15 OD 77 M C 47 60 10 600
31 9 OS 82 F C 12 5 180 900
32 13 OD 80 F C NK IVMP 1000 mg×3 days 80 4 3080
33 19 OD 80 F C NK 40 12 480
34 22 OD 77 F C 85 IVMP 1000 mg×3 days 80 mg×3 days
6 3240
35 20 OD 89 M C NK 60×5 days, IVMP 1000 mg×3 days 8 3300

AA, African American; Bx, ; C, Caucasian; ESR, erythrocyte sedimentation rate; F, Female; IV, intravenous; IVMP, Intravenous methylprednisolone; M, Male; NK, not known; OD, right eye; OS, left eye